256 related articles for article (PubMed ID: 16940443)
1. BRCA1 negatively regulates the cancer-associated aromatase promoters I.3 and II in breast adipose fibroblasts and malignant epithelial cells.
Lu M; Chen D; Lin Z; Reierstad S; Trauernicht AM; Boyer TG; Bulun SE
J Clin Endocrinol Metab; 2006 Nov; 91(11):4514-9. PubMed ID: 16940443
[TBL] [Abstract][Full Text] [Related]
2. A novel role of sodium butyrate in the regulation of cancer-associated aromatase promoters I.3 and II by disrupting a transcriptional complex in breast adipose fibroblasts.
Deb S; Zhou J; Amin SA; Imir AG; Yilmaz MB; Lin Z; Bulun SE
J Biol Chem; 2006 Feb; 281(5):2585-97. PubMed ID: 16303757
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E(2) induces breast cancer related aromatase promoters via activation of p38 and c-Jun NH(2)-terminal kinase in adipose fibroblasts.
Chen D; Reierstad S; Lin Z; Lu M; Brooks C; Li N; Innes J; Bulun SE
Cancer Res; 2007 Sep; 67(18):8914-22. PubMed ID: 17875734
[TBL] [Abstract][Full Text] [Related]
4. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.
Zhou J; Gurates B; Yang S; Sebastian S; Bulun SE
Cancer Res; 2001 Mar; 61(5):2328-34. PubMed ID: 11280806
[TBL] [Abstract][Full Text] [Related]
5. Regulation of aromatase expression in breast cancer tissue.
Bulun SE; Lin Z; Zhao H; Lu M; Amin S; Reierstad S; Chen D
Ann N Y Acad Sci; 2009 Feb; 1155():121-31. PubMed ID: 19250199
[TBL] [Abstract][Full Text] [Related]
6. Melatonin suppresses aromatase expression and activity in breast cancer associated fibroblasts.
Knower KC; To SQ; Takagi K; Miki Y; Sasano H; Simpson ER; Clyne CD
Breast Cancer Res Treat; 2012 Apr; 132(2):765-71. PubMed ID: 22237979
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressor BRCA1 inhibits a breast cancer-associated promoter of the aromatase gene (CYP19) in human adipose stromal cells.
Ghosh S; Lu Y; Katz A; Hu Y; Li R
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E246-52. PubMed ID: 16940470
[TBL] [Abstract][Full Text] [Related]
8. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients.
Agarwal VR; Bulun SE; Leitch M; Rohrich R; Simpson ER
J Clin Endocrinol Metab; 1996 Nov; 81(11):3843-9. PubMed ID: 8923826
[TBL] [Abstract][Full Text] [Related]
9. Cloning and characterization of a novel endothelial promoter of the human CYP19 (aromatase P450) gene that is up-regulated in breast cancer tissue.
Sebastian S; Takayama K; Shozu M; Bulun SE
Mol Endocrinol; 2002 Oct; 16(10):2243-54. PubMed ID: 12351690
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.
Rubin GL; Zhao Y; Kalus AM; Simpson ER
Cancer Res; 2000 Mar; 60(6):1604-8. PubMed ID: 10749129
[TBL] [Abstract][Full Text] [Related]
11. Tissue-specific regulation of aromatase promoter II by the orphan nuclear receptor LRH-1 in breast adipose stromal fibroblasts.
Chand AL; Herridge KA; Howard TL; Simpson ER; Clyne CD
Steroids; 2011 Jul; 76(8):741-4. PubMed ID: 21392518
[TBL] [Abstract][Full Text] [Related]
12. Aromatase in aging women.
Bulun SE; Zeitoun K; Sasano H; Simpson ER
Semin Reprod Endocrinol; 1999; 17(4):349-58. PubMed ID: 10851574
[TBL] [Abstract][Full Text] [Related]
13. JunD and JunB integrate prostaglandin E2 activation of breast cancer-associated proximal aromatase promoters.
Chen D; Reierstad S; Fang F; Bulun SE
Mol Endocrinol; 2011 May; 25(5):767-75. PubMed ID: 21393445
[TBL] [Abstract][Full Text] [Related]
14. Aromatase activity induction in human adipose fibroblasts by retinoic acids via retinoic acid receptor α.
Wilde J; Erdmann M; Mertens M; Eiselt G; Schmidt M
J Mol Endocrinol; 2013 Oct; 51(2):247-60. PubMed ID: 24023268
[TBL] [Abstract][Full Text] [Related]
15. Pioglitazone, a PPARγ agonist, suppresses CYP19 transcription: evidence for involvement of 15-hydroxyprostaglandin dehydrogenase and BRCA1.
Subbaramaiah K; Howe LR; Zhou XK; Yang P; Hudis CA; Kopelovich L; Dannenberg AJ
Cancer Prev Res (Phila); 2012 Oct; 5(10):1183-94. PubMed ID: 22787115
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic mechanisms regulating CYP19 transcription in human breast adipose fibroblasts.
Knower KC; To SQ; Simpson ER; Clyne CD
Mol Cell Endocrinol; 2010 Jun; 321(2):123-30. PubMed ID: 20211687
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2 inhibits p53 in human breast adipose stromal cells: a novel mechanism for the regulation of aromatase in obesity and breast cancer.
Wang X; Docanto MM; Sasano H; ; Lo C; Simpson ER; Brown KA
Cancer Res; 2015 Feb; 75(4):645-55. PubMed ID: 25634217
[TBL] [Abstract][Full Text] [Related]
18. Involvement of early growth response factors in TNFα-induced aromatase expression in breast adipose.
To SQ; Simpson ER; Knower KC; Clyne CD
Breast Cancer Res Treat; 2013 Feb; 138(1):193-203. PubMed ID: 23338760
[TBL] [Abstract][Full Text] [Related]
19. Aromatase activity and expression in breast cancer and benign breast tissue stromal cells.
Santner SJ; Pauley RJ; Tait L; Kaseta J; Santen RJ
J Clin Endocrinol Metab; 1997 Jan; 82(1):200-8. PubMed ID: 8989259
[TBL] [Abstract][Full Text] [Related]
20. CCAAT/enhancer binding protein delta up-regulates aromatase promoters I.3/II in breast cancer epithelial cells.
Kijima I; Ye J; Glackin C; Chen S
Cancer Res; 2008 Jun; 68(11):4455-64. PubMed ID: 18519709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
